Explore the importance of clinical trials for ovarian cancer treatments, highlighting innovative therapies and the need for early patient access.
Video content is prompted by the following:
Approaches to Treatment, Sequencing, and Heavily Pretreated Patients With Novel Agents
Key Discussion Points:
Notable Insights:
“Reach out early. Once someone’s platinum resistant, make sure they’re tested for folate. Make sure they’re tested for HER2...make sure you’ve got molecular testing done by whatever platform you want to do.”
“Find a local friend that has trials open and just run things by them so we can get patients access to these medications that are actually working.”
Ovarian Cancer Survival Gaps Persist Across Racial, Ethnic Groups
May 27th 2025Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer survival disparities among racial and ethnic subgroups, particularly within disaggregated Asian American, Native Hawaiian, and Pacific Islander populations.
Read More